Chander Parkash Dora

1.5k total citations
29 papers, 1.2k citations indexed

About

Chander Parkash Dora is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Chander Parkash Dora has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmaceutical Science, 11 papers in Biomaterials and 9 papers in Molecular Biology. Recurrent topics in Chander Parkash Dora's work include Nanoparticle-Based Drug Delivery (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Drug Solubulity and Delivery Systems (7 papers). Chander Parkash Dora is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Drug Solubulity and Delivery Systems (7 papers). Chander Parkash Dora collaborates with scholars based in India, United States and United Kingdom. Chander Parkash Dora's co-authors include Sanyog Jain, Varun Kushwah, Sarasija Suresh, Charan Singh, Sameer S. Katiyar, Aakash Deep, Sunil Kumar Jena, Ashok Kumar Datusalia, Ashish Kumar Agrawal and Kaushik Kuche and has published in prestigious journals such as Carbohydrate Polymers, Acta Biomaterialia and International Journal of Pharmaceutics.

In The Last Decade

Chander Parkash Dora

28 papers receiving 1.2k citations

Peers

Chander Parkash Dora
Chander Parkash Dora
Citations per year, relative to Chander Parkash Dora Chander Parkash Dora (= 1×) peers Sameer S. Katiyar

Countries citing papers authored by Chander Parkash Dora

Since Specialization
Citations

This map shows the geographic impact of Chander Parkash Dora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chander Parkash Dora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chander Parkash Dora more than expected).

Fields of papers citing papers by Chander Parkash Dora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chander Parkash Dora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chander Parkash Dora. The network helps show where Chander Parkash Dora may publish in the future.

Co-authorship network of co-authors of Chander Parkash Dora

This figure shows the co-authorship network connecting the top 25 collaborators of Chander Parkash Dora. A scholar is included among the top collaborators of Chander Parkash Dora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chander Parkash Dora. Chander Parkash Dora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swami, Rajan, et al.. (2025). A review on biomacromolecular ligand-directed nanoparticles: New era in macrophage targeting. International Journal of Biological Macromolecules. 306(Pt 4). 141740–141740. 5 indexed citations
2.
Jain, Sanyog, et al.. (2025). Phospholipid Complex-based Topical Gel for Codelivery of Erlotinib and Methotrexate in Psoriasis. AAPS PharmSciTech. 26(6). 172–172.
3.
Dora, Chander Parkash, Rajan Swami, Predeepkumar Narayanappa Shiroorkar, et al.. (2022). Nanomaterials in Dentistry: Current Applications and Future Scope. Nanomaterials. 12(10). 1676–1676. 61 indexed citations
4.
Katiyar, Sameer S., Ravindra Patil, Rohan Ghadi, et al.. (2022). Lipid- and TPGS-Based Core–Shell-Type Nanocapsules Endowed with High Paclitaxel Loading and Enhanced Anticancer Potential. AAPS PharmSciTech. 23(7). 238–238. 5 indexed citations
5.
Katiyar, Sameer S., Rohan Ghadi, Varun Kushwah, Chander Parkash Dora, & Sanyog Jain. (2020). Lipid and Biosurfactant Based Core–Shell-Type Nanocapsules Having High Drug Loading of Paclitaxel for Improved Breast Cancer Therapy. ACS Biomaterials Science & Engineering. 6(12). 6760–6769. 17 indexed citations
6.
Kuche, Kaushik, et al.. (2019). Drug-Phospholipid Complex—a Go Through Strategy for Enhanced Oral Bioavailability. AAPS PharmSciTech. 20(2). 43–43. 83 indexed citations
7.
Katiyar, Sameer S., Varun Kushwah, Chander Parkash Dora, Ravindra Patil, & Sanyog Jain. (2019). Design and Toxicity Evaluation of Novel Fatty Acid-Amino Acid-Based Biocompatible Surfactants. AAPS PharmSciTech. 20(5). 186–186. 20 indexed citations
8.
Katiyar, Sameer S., Varun Kushwah, Chander Parkash Dora, & Sanyog Jain. (2018). Lipid and TPGS based novel core-shell type nanocapsular sustained release system of methotrexate for intravenous application. Colloids and Surfaces B Biointerfaces. 174. 501–510. 10 indexed citations
9.
Katiyar, Sameer S., Varun Kushwah, Chander Parkash Dora, & Sanyog Jain. (2018). Novel biosurfactant and lipid core-shell type nanocapsular sustained release system for intravenous application of methotrexate. International Journal of Pharmaceutics. 557. 86–96. 8 indexed citations
10.
Dora, Chander Parkash, Varun Kushwah, Sameer S. Katiyar, et al.. (2017). Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid. International Journal of Pharmaceutics. 534(1-2). 1–13. 47 indexed citations
11.
Jain, Sanyog, et al.. (2017). Formulation, optimization, and in vitro–in vivo evaluation of olmesartan medoxomil nanocrystals. Drug Delivery and Translational Research. 7(2). 292–303. 19 indexed citations
12.
Kushwah, Varun, Ashish Kumar Agrawal, Chander Parkash Dora, et al.. (2017). Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment. Pharmaceutical Research. 34(11). 2295–2311. 45 indexed citations
13.
Dora, Chander Parkash, Varun Kushwah, Sameer S. Katiyar, et al.. (2017). Improved metabolic stability and therapeutic efficacy of a novel molecular gemcitabine phospholipid complex. International Journal of Pharmaceutics. 530(1-2). 113–127. 46 indexed citations
14.
Dora, Chander Parkash, et al.. (2017). Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability. Colloids and Surfaces B Biointerfaces. 154. 10–20. 69 indexed citations
15.
Dora, Chander Parkash, et al.. (2015). Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico , in vitro and in vivo evaluation. Carbohydrate Polymers. 134. 547–556. 88 indexed citations
16.
Dora, Chander Parkash, Francesco Trotta, Varun Kushwah, et al.. (2015). Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability. Carbohydrate Polymers. 137. 339–349. 122 indexed citations
17.
Dora, Chander Parkash, et al.. (2015). A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation. Pharmaceutical Development and Technology. 21(5). 554–562. 93 indexed citations
18.
Dora, Chander Parkash, et al.. (2014). Development and evaluation of PEGylated Enoxaparin: A novel approach for enhanced anti-Xa activity. Bioorganic Chemistry. 54. 1–6. 13 indexed citations
19.
Jena, Sunil Kumar, Charan Singh, Chander Parkash Dora, & Sarasija Suresh. (2014). Development of tamoxifen-phospholipid complex: Novel approach for improving solubility and bioavailability. International Journal of Pharmaceutics. 473(1-2). 1–9. 99 indexed citations
20.
Dora, Chander Parkash, Shailendra Kumar Singh, Sanjeev Kumar, Ashok Kumar Datusalia, & Aakash Deep. (2010). Development and characterization of nanoparticles of glibenclamide by solvent displacement method.. PubMed. 67(3). 283–90. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026